Animalcare Group PLC
LSE:ANCR
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Animalcare Group PLC
Operating Income
Animalcare Group PLC
Operating Income Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Animalcare Group PLC
LSE:ANCR
|
Operating Income
£5m
|
CAGR 3-Years
1%
|
CAGR 5-Years
8%
|
CAGR 10-Years
5%
|
|
|
GlaxoSmithKline PLC
LSE:GSK
|
Operating Income
£9.6B
|
CAGR 3-Years
5%
|
CAGR 5-Years
10%
|
CAGR 10-Years
7%
|
|
|
AstraZeneca PLC
LSE:AZN
|
Operating Income
$14B
|
CAGR 3-Years
17%
|
CAGR 5-Years
26%
|
CAGR 10-Years
10%
|
|
|
Hikma Pharmaceuticals PLC
LSE:HIK
|
Operating Income
$742m
|
CAGR 3-Years
13%
|
CAGR 5-Years
7%
|
CAGR 10-Years
7%
|
|
|
Allergy Therapeutics PLC
LSE:AGY
|
Operating Income
-£33.5m
|
CAGR 3-Years
-7%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-20%
|
|
|
A
|
Alliance Pharma PLC
LSE:APH
|
Operating Income
£33.4m
|
CAGR 3-Years
3%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
11%
|
|
Animalcare Group PLC
Glance View
Animalcare Group Plc engages in the development, sale, and supply of generic veterinary medicines and animal identification products. The company is headquartered in Ripon, North Yorkshire. The company went IPO on 2008-01-15. The firm is focused on developing and commercializing prescription and over-the-counter pharmaceutical products. The firm operates in three categories within the veterinary market, which includes Companion Animals, Equine and Production Animals. The company manages international supply chain, including specialist veterinary wholesalers and distributors. The firm develops, supplies and markets products and services to the veterinary profession. The company focuses on therapeutic areas, which includes pain management, dermatology and anti-infectives. The Company’s product pipeline is Daxocox, which is a differentiated COX-2 inhibitor for the treatment of chronic pain in dogs.
See Also
What is Animalcare Group PLC's Operating Income?
Operating Income
5m
GBP
Based on the financial report for Jun 30, 2025, Animalcare Group PLC's Operating Income amounts to 5m GBP.
What is Animalcare Group PLC's Operating Income growth rate?
Operating Income CAGR 10Y
5%
Over the last year, the Operating Income growth was 9%. The average annual Operating Income growth rates for Animalcare Group PLC have been 1% over the past three years , 8% over the past five years , and 5% over the past ten years .
